Premium
CLINICAL EFFICACY AND COST‐EFFECTIVENESS ANALYSIS OF CEFEPIME OR PIPERACILLIN/TAZOBACTAM BOTH WITH CIPROFLOXACIN IN MICU PATIENTS WITH SEVERE PNEUMONIA
Author(s) -
Myung Goo Lee
Publication year - 2018
Publication title -
respirology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.857
H-Index - 85
eISSN - 1440-1843
pISSN - 1323-7799
DOI - 10.1111/resp.13420_286
Subject(s) - medicine , cefepime , piperacillin/tazobactam , intensive care medicine , pneumonia , piperacillin , tazobactam , ventilator associated pneumonia , ciprofloxacin , antibiotics , microbiology and biotechnology , imipenem , antibiotic resistance , pseudomonas aeruginosa , genetics , bacteria , biology
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom